Allergan Plans $12-Million Research Facility in New Jersey

share this news:
Facebooktwittergoogle_plusredditpinterestlinkedintumblrmail

California-based Allergan Inc., the pharmaceutical company that produces Botox, is building a new $12 million research facility in New Jersey, Gov. Chris Christie has announced. New Jersey officials reportedly are poised to offer the company a 10-year, $17-million state grant to build the facility, which is expected to create about 400 jobs.

“Creating good paying, private sector jobs that are sustainable over the long term is the number one priority of my administration,” Christie said in a statement Monday.
The new building is expected to be around 100,000 square feet, according to Kevin Roberts, a spokesman for the governor.  He said that possible locations include Florham Park in Morris County and Piscataway in Middlesex. Allergan currently employs 20 people at a subsidiary in Bedminister, NJ.

“This expansion will enable us to further tap into the talent of New Jersey residents,” said Dr. Scott Whitcup, Allergan executive vice president for R&D, in a statement.

The New Jersey Economic Development Authority will vote on awarding the Business Employment Incentive Program grant to Allergan during a board meeting today.

Connect With Us:
Facebooktwittergoogle_pluspinterestlinkedinrssyoutubetumblrinstagram
SHARE
Previous articleFord Plans $1.1 Billion Upgrade of Claycomo Plant
Next articleDoing Your Homework
Business Facilities is a leading full-service media brand specializing in the site selection marketplace. Through a bi-monthly magazine, e-mail newsletters, a news portal, and its LiveXchange event, Business Facilities has created a dynamic community for C-level executives and economic development organizations.

You Might Like: